SG11201804602SA - Nutritional composition - Google Patents

Nutritional composition

Info

Publication number
SG11201804602SA
SG11201804602SA SG11201804602SA SG11201804602SA SG11201804602SA SG 11201804602S A SG11201804602S A SG 11201804602SA SG 11201804602S A SG11201804602S A SG 11201804602SA SG 11201804602S A SG11201804602S A SG 11201804602SA SG 11201804602S A SG11201804602S A SG 11201804602SA
Authority
SG
Singapore
Prior art keywords
nutritional composition
less
protein
whey
weight
Prior art date
Application number
SG11201804602SA
Inventor
Kentaro Ito
Hisae Kume
Taishi Isobe
Tadahito Maekawa
Kazuo Dairiki
Kinya Ashida
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of SG11201804602SA publication Critical patent/SG11201804602SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nutritional Composition A high-calorie nutritional composition that has good flavor and stable physicality is provided. The nutritional composition contains a protein source. The protein source of the nutritional composition contains whey protein and whey peptide. The ratio of the sum of the weight of whey protein and whey peptide to the total weight of the protein source is not less than 80 % by weight. The protein energy ratio of the nutritional composition is not less than 16% and less than 50%. The nutritional composition is acidic. The nutritional composition has the caloric density of not less than 100 kcal/100 ml. [No Suitable Figure]
SG11201804602SA 2015-12-03 2016-11-28 Nutritional composition SG11201804602SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015236300 2015-12-03
PCT/JP2016/085204 WO2017094669A1 (en) 2015-12-03 2016-11-28 Nutritional composition

Publications (1)

Publication Number Publication Date
SG11201804602SA true SG11201804602SA (en) 2018-06-28

Family

ID=58796740

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201804602SA SG11201804602SA (en) 2015-12-03 2016-11-28 Nutritional composition

Country Status (6)

Country Link
JP (1) JP7300243B2 (en)
CN (1) CN108430490A (en)
HK (1) HK1253384A1 (en)
SG (1) SG11201804602SA (en)
TW (1) TWI712367B (en)
WO (1) WO2017094669A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7198749B2 (en) * 2017-06-01 2023-01-04 株式会社明治 nutritional composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932271A (en) * 1990-05-24 1999-08-03 Meiji Milk Products, Co., Ltd. Fabricated rice
WO2000023925A2 (en) 1998-10-16 2000-04-27 Commerce One, Inc. Documents for commerce in trading partner networks and interface definitions based on the documents
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
JP4993589B2 (en) * 2007-03-30 2012-08-08 テルモ株式会社 Liquid nutrition composition containing whey peptide
WO2008136420A1 (en) * 2007-04-27 2008-11-13 Meiji Dairies Corporation Liquid nutritional composition containing whey protein at high concentration, and method for production thereof
WO2009113845A1 (en) * 2008-03-12 2009-09-17 N.V. Nutricia High protein liquid enteral nutritional composition
WO2009157759A1 (en) * 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
WO2010002242A1 (en) * 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
CN103005464B (en) * 2008-10-17 2015-01-07 雀巢产品技术援助有限公司 Whey protein compositions, methods and uses
US20120195873A1 (en) * 2009-07-20 2012-08-02 Nestec S.A. Methods of attenuating the loss of functional status
TWI612902B (en) * 2009-11-30 2018-02-01 Meiji Co Ltd Use of a composition for manufacturing an improved intestinal functional composition and preparation method thereof
EP2592944B1 (en) * 2010-07-18 2019-12-25 Glanbia Nutritionals (Ireland) Ltd. High-protein beverages comprising whey protein
TWI629992B (en) * 2011-05-27 2018-07-21 明治股份有限公司 Compositions for prevention and/or improvement of irreversible metabolic defect accompanying cancer
CN103957720B (en) * 2011-11-30 2016-05-25 株式会社明治 Improving intestinal flora alimentation composition
JP5763024B2 (en) * 2012-09-07 2015-08-12 株式会社明治 Nutritional composition
CN103251049B (en) * 2013-05-08 2014-11-05 盘锐伦 Antioxidant composition, preparation method of antioxidant composition and antioxidant food
CN105338826A (en) * 2013-06-27 2016-02-17 飞鱼有限公司 Use of a composition comprising fish oil and juice for the treatment of inflammation
WO2015094767A1 (en) * 2013-12-18 2015-06-25 Abbott Laboratories Methods for maintaining or increasing bodyweight using decaffeinated green tea extract

Also Published As

Publication number Publication date
JP7300243B2 (en) 2023-06-29
CN108430490A (en) 2018-08-21
WO2017094669A1 (en) 2017-06-08
TW201731395A (en) 2017-09-16
HK1253384A1 (en) 2019-06-14
JPWO2017094669A1 (en) 2018-09-20
TWI712367B (en) 2020-12-11

Similar Documents

Publication Publication Date Title
NZ711956A (en) Rice protein supplements
BR112012017690A2 (en) Nutritional emulsions comprising calcium hmb
BR112012031183A2 (en) substantially clear nutritional liquids comprising hmb and soluble calcium protein
WO2014172631A3 (en) Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones
IN2015DN03322A (en)
MX2016016871A (en) A method for improving the nutritional value of animal feed.
MX2012008786A (en) Nutritional emulsions comprising calcium hmb and soluble protein.
MX2016008495A (en) Pediatric nutritional composition with milk peptides for healthy growth and development.
IN2014CN02970A (en)
WO2016030644A3 (en) Method for inducing the synthesis of phycobiliproteins
MX344481B (en) Fortified milk-based nutritional compositions.
MX2018000600A (en) Nutritional compositions comprising hydrolysed casein.
AR087059A1 (en) FORMULATION CONTAINING MILK AS A BASE
MX2015013165A (en) Low calorie infant formula containing beta-hydroxy-beta-methylbut yric acid.
MX2013001793A (en) Product for the upper gastric sphere.
SG11201804602SA (en) Nutritional composition
AR093425A1 (en) LACTOBACILLUS RHAMNOSUS CEPA TO REDUCE BODY FAT ACCUMULATION
PH12016501947B1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
WO2013184879A3 (en) Pumpable fat compositions
MX345948B (en) Use of nisin resistant mutant strains of lactobacilli for reducing the post acidification in food products.
PH12018500340A1 (en) Kit for delivering a multi-layered beverage
PH22014000753Y1 (en) Fish canton noodles
MX2015014450A (en) Lactobacillus rhamnosus strain for regulating lipid metabolism.
PH22014000687U1 (en) Fish and vegetable canton noodles
PH22014000752Y1 (en) Vegetable canton noodles